Last reviewed · How we verify

NCT07366164: SIMPLY

Hemodynamic Optimization Using an Artificial Intelligenze System

Recruiting now NA Last updated 26 January 2026
What this trial tests

NA trial testing assisted fluid therapy in Hemodynamic (MAP) Stability in 80 participants. Currently enrolling.

Timeline
1 October 2025
Primary endpoint
1 June 2026
1 January 2027

Quick facts

Lead sponsorFondazione Policlinico Universitario Agostino Gemelli IRCCS
PhaseNA
StatusRecruiting now
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposeother
Enrollment80
Start date1 October 2025
Primary completion1 June 2026
Estimated completion1 January 2027
Sites1 location across Italy

Drugs / interventions tested

Conditions studied

Sponsor

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Who can join

18 and older, any sex, with Hemodynamic (MAP) Stability or Fluid Management. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study will investigate the impact of using an automated fluid management system on intraoperative fluid therapy in patients undergoing colorectal surgery. The aim is to evaluate whether automated guidance can optimize hemodynamic stability and reduce the incidence of arterial hypotension,

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Fondazione Policlinico Universitario Agostino Gemelli IRCCS trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07366164.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing